Across TCGA pan-cancer cohorts, LMX1A-AS1 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of LMX1A-AS1’s most consistent transcriptional readouts.
The strongest signal is observed in breast invasive carcinoma (BRCA), where LMX1A-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types LMX1A-AS1 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.
BRCA are the cancer types where LMX1A-AS1 tumor–normal differential expression is most reproducible.